Akil Merchant, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Keck Hospital of USC - Medical Center USC Norris Comprehensive Cancer Center
Dr. Akil Merchant graduated from the Baylor College of Medicine and also completed his residency program there. Then, he pursued a fellowship at the Johns Hopkins University. Dr. Merchant is specialized in Hematology and board certified in Medical Oncology. He has been in practice for more than 11 years and is affiliated with the Keck Hospital of USC. During his career, he has run two clinical trials and has also contributed to various clinical research publications.
Baylor College of Medicine
Medical School
Baylor College of Medicine
Residency
Johns Hopkins University
Fellowship
American Board of Internal Medicine - Hematology
American Board of Internal Medicine - Oncology
Activation of liver x receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma.
Agarwal, J. R.,Wang, Q.,Tanno, T.,Rasheed, Z.,Merchant, A.,Ghosh, N.,Borrello, I.,Huff, C. A.,Parhami, F.,Matsui, W.; Mol. Cancer Ther.. 2014 May 09.
See more >>Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation.
Lim, Y.,Hedayati, M.,Merchant, A. A.,Zhang, Y.,Yu, H. H.,Kastan, M. B.,Matsui, W.,Deweese, T. L.; Int. J. Radiat. Oncol. Biol. Phys.. 2012 Nov 1.
See more >>Not so benign haematology: anaemia of the elderly.
Merchant, A.A., Roy, C.N.; Br J Haematol. 2012 Jan.
See more >>